While the overall number of patent applications from companies remained stable in 2024, those for medical technology and pharmaceuticals experienced a decline, according to the annual Patent Index published on Tuesday by the European Patent Office (EPO).
The EPO registered 199,264 patent applications last year, following three years of growth. Applications from Europe increased by 0.3%, while those from outside Europe fell slightly by 0.4%.
